MetricSide LogoMetricSide
Learn
  1. Home
  2. Companies
  3. Healthcare
  4. WAY
OverviewMetricsPricesRevenue & ProfitAssets & LiabilitiesCash FlowMarginsPrice RatiosOthers
MetricSide

Standardized stock fundamentals and valuation metrics. Analyze revenue, EBITDA, free cash flow, and more with interactive charts.

Stock Sectors

  • Technology
  • Healthcare
  • Financials
  • Consumer
  • Industrials
  • Energy
  • Real Estate
  • Materials

Legal & Contact

  • Terms of Service
  • Privacy Policy
  • Contact Us
Not Financial Advice: MetricSide is a data aggregation and visualization tool. Nothing on this website constitutes investment advice, a recommendation, or a solicitation to buy or sell any security. All data is provided for informational and educational purposes only. Past performance is not indicative of future results. Always consult a qualified financial professional before making investment decisions. Data accuracy is not guaranteed — verify critical information against official sources.

© 2026 MetricSide. All rights reserved.

Waystar Holding (WAY) Stock Fundamentals, Analysis & Risk Signals

Health score, competitive moat, risk signals, and key metrics at a glance.

NasdaqGS•Healthcare•Health Information Services
B
GoodMetricSide Score: 79/100
ProfitabilityProfit23/30
GrowthGrowth17/25
Balance SheetBalance21/25
Cash QualityCash18/20
Price & Volume
Market Cap $4.50B

Waystar Holding Corp. develops a cloud-based software solution for healthcare payments. Its platform offers financial clearance, patient financial care, claim and payer payment management, denials prevention and recovery, clinical integrity and revenue capture, and analytics and reporting solutions. It primarily serves healthcare industry. The company was founded in 2017 and is headquartered in Lehi, Utah.

Moat Signals

Competitive analysis based on 8 quarters of fundamental data

Pricing Power

Strong Moat

Operating margins are expanding at ~18.8%, suggesting durable pricing power and cost discipline.

Competitive Advantage

Moderate Moat

ROE is positive at ~2.3% on average, adequate but below the threshold typically associated with wide moats.

Risk Signals

Data-driven red flags and warnings across 8 quarters

Some Concerns

Margin Pressure

Healthy

Margins are stable or improving at ~22.9% — no sign of cost or pricing stress.

Earnings Quality

Healthy

FCF covers net income by 5.4x on average — earnings are well-supported by cash generation.

Leverage Risk

Healthy

D/E ratio is 0.4 — conservative capital structure with low financial risk.

Revenue Decline

Healthy

Revenue is stable or growing over recent quarters — demand appears durable.

Cash Burn

Healthy

Free cash flow is consistently positive — the business self-funds without external capital reliance.

Share Dilution

Red Flag

Shares outstanding increased 43.5% — significant dilution, likely from stock compensation or capital raises.

Metrics at a Glance

as of March 2026

Revenue & Profit

Revenue, EBITDA, operating income, net income, EPS, and shares

TTM Revenue
$1.16B
3.6%
Q. Revenue
$313.87M
TTM EBITDA
$413.18M
1.0%
TTM Op. Income
$264.56M
40.0%
Q. Op. Income
$80.47M
TTM Net Income
$126.10M
1143.1%
Q. Net Income
$43.28M
EPS
$0.23
Shares Out.
$191.67M
11.3%
$1.16B in TTM revenue declined 3.6% YoY, reaching $313.87M last quarter. TTM EBITDA of $413.18M and TTM operating income of $264.56M shows growth is flowing through. Net income of $126.10M TTM confirms the company is converting revenue into profit. Revenue is contracting — assess whether this is cyclical or structural.

Margins

Gross, EBITDA, operating, and net margin trends

EBITDA Margin
38.8%
Op. Margin
25.6%
0.8%
Net Margin
13.8%
20.8%
Op. margin of 25.6% is up 0.2% YoY — cost efficiency is improving. Net margin at 13.8%.

Price Ratios

P/E, P/S, P/B, EV/EBITDA, FCF yield, and earnings yield

P/E Ratio
35.7x
P/S Ratio
3.9x
P/B Ratio
1.1x
At 35.7x P/E, the stock trades at a premium — the market expects above-average growth. P/S of 3.9x and P/B of 1.1x provide additional context. The premium P/E is not backed by strong revenue growth — the stock may be overvalued.

Assets & Liabilities

Total assets, cash, debt, book value, and leverage

Total Assets
$5.84B
Cash
$34.34M
Long-Term Debt
$1.46B
Book Value
$3.94B
D/E Ratio
0.4
Debt/EBITDA
11.9
With $5.84B in assets and $1.46B in long-term debt, the D/E of 0.4and book value of $3.94B — shows a conservative capital structure — the company has a strong financial cushion to weather downturns.

Cash Flow

Operating cash flow, free cash flow, FCF margin, and earnings quality

Op. Cash Flow
$84.91M
Free Cash Flow
$69.59M
18.3%
FCF Margin
6.0%
FCF / Net Income
1.6
FCF of $69.59M on $84.91M in operating cash flow. The FCF / Net Income ratio of 0.6x indicates partial cash conversion — earnings quality needs attention.

Related Stocks in Healthcare

View Sector
NVDA$4.57T
Nvidia
Semiconductors
GOOG$3.96T
Alphabet Inc. (Class C)
Internet Content & Information
AAPL$3.67T
Apple Inc.
Consumer Electronics
GOOGL$3.66T
Alphabet Inc. (Class A)
Internet Content & Information
MSFT$3.46T
Microsoft
Software - Infrastructure
AMZN$2.56T
Amazon
Internet Retail
META$1.66T
Meta Platforms
Internet Content & Information
AVGO$1.63T
Broadcom
Semiconductors

Cash Generation

Strong Moat

Free cash flow is consistently positive and growing — a hallmark of a capital-light business that can self-fund growth.

Demand Durability

Weak Moat

Revenue has been flat or declining over recent quarters, which may indicate eroding demand or competitive pressure.